A Clinical Study of Two Dentinal Hypersensitivity Treatments Used With Normal Oral Hygiene
Study Details
Study Description
Brief Summary
This study will compare the safety and effectiveness of normal oral hygiene with two different marketed dentifrices, on longer term dentinal hypersensitivity response following use of potassium oxalate desensitizers.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: oxalate liquid & gel plus SnF2 paste Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Stannous fluoride paste, self applied |
Device: Potassium oxalate
Professionally applied (liquid) and self applied (gel)
Drug: Stannous fluoride paste
Toothpaste used by subject
Other Names:
|
Other: oxalate liquid & gel plus NaF paste Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Sodium fluoride paste, self applied |
Device: Potassium oxalate
Professionally applied (liquid) and self applied (gel)
Drug: Sodium fluoride paste
Toothpaste used by subject
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Change From Baseline Air Challenge [60 days]
The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows: 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subjects responds to stimulus and requests discontinuation or moves from stimulus, 3: tooth/subject responds to stimulus considers stimulus to be painful, and requests discontinuation of the stimulus. The higher the Schiff score, the more sensitive the tooth. The mean change from Baseline was calculated for this measure.
Secondary Outcome Measures
- Change From Baseline Visual Analog Scale [60 days]
Visual Analog Scale (VAS) - subjects are asked to look at a VAS and designate the level of hypersensitivity they experienced as a result of the thermal and water challenges using a continuum scale of 0 = No tooth pain up to 100 = Worst tooth pain ever experienced.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Be at least 18 years of age
-
Provide written informed consent prior to participation and be given a signed copy of the informed consent form
-
Complete a confidentiality disclosure agreement
-
Be in good general health as determined by the Investigator/designee
-
Have at least one tooth with a Schiff sensitivity score of at least 1 in response to the air challenge.
Exclusion Criteria:
-
Self-reported pregnancy or nursing
-
Severe periodontal disease, as characterized by purulent exudate, generalized mobility, and/or severe recession
-
Active treatment of periodontitis
-
Fixed facial orthodontic appliances
-
A history of kidney stones
-
Known allergies to the following ingredients; aqua, glycerin, cellulose gum, dipotassium oxalate, carbomer, sodium hydroxide, sodium benzoate, and potassium sorbate
-
Any diseases or conditions that might interfere with the safe completion of the study
-
An inability to undergo any study procedures.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Chad J Anderson DMD Inc | Fresno | California | United States | 93730 |
Sponsors and Collaborators
- Procter and Gamble
Investigators
- Principal Investigator: Chad J Anderson, MS, DMD, Chad J Anderson DMD Inc
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2014069
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Oxalate Liquid & Gel Plus SnF2 Paste | Oxalate Liquid & Gel Plus NaF Paste |
---|---|---|
Arm/Group Description | Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Stannous fluoride paste, self applied Potassium oxalate: Professionally applied (liquid) and self applied (gel) Stannous fluoride paste: Toothpaste used by subject | Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Sodium fluoride paste, self applied Potassium oxalate: Professionally applied (liquid) and self applied (gel) Sodium fluoride paste: Toothpaste used by subject |
Period Title: Overall Study | ||
STARTED | 15 | 15 |
COMPLETED | 14 | 15 |
NOT COMPLETED | 1 | 0 |
Baseline Characteristics
Arm/Group Title | Oxalate Liquid & Gel Plus SnF2 Paste | Oxalate Liquid & Gel Plus NaF Paste | Total |
---|---|---|---|
Arm/Group Description | Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Stannous fluoride paste, self applied Potassium oxalate: Professionally applied (liquid) and self applied (gel) Stannous fluoride paste: Toothpaste used by subject | Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Sodium fluoride paste, self applied Potassium oxalate: Professionally applied (liquid) and self applied (gel) Sodium fluoride paste: Toothpaste used by subject | Total of all reporting groups |
Overall Participants | 15 | 15 | 30 |
Age (Count of Participants) | |||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
15
100%
|
15
100%
|
30
100%
|
>=65 years |
0
0%
|
0
0%
|
0
0%
|
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
41.5
(10.97)
|
44.9
(12.52)
|
43.2
(11.69)
|
Sex: Female, Male (Count of Participants) | |||
Female |
14
93.3%
|
14
93.3%
|
28
93.3%
|
Male |
1
6.7%
|
1
6.7%
|
2
6.7%
|
Race/Ethnicity, Customized (Count of Participants) | |||
Hispanic |
1
6.7%
|
2
13.3%
|
3
10%
|
American Indian |
0
0%
|
1
6.7%
|
1
3.3%
|
Asian Oriental |
2
13.3%
|
0
0%
|
2
6.7%
|
Black |
2
13.3%
|
0
0%
|
2
6.7%
|
Caucasian |
10
66.7%
|
11
73.3%
|
21
70%
|
Multi-Racial |
0
0%
|
1
6.7%
|
1
3.3%
|
Outcome Measures
Title | Change From Baseline Air Challenge |
---|---|
Description | The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows: 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subjects responds to stimulus and requests discontinuation or moves from stimulus, 3: tooth/subject responds to stimulus considers stimulus to be painful, and requests discontinuation of the stimulus. The higher the Schiff score, the more sensitive the tooth. The mean change from Baseline was calculated for this measure. |
Time Frame | 60 days |
Outcome Measure Data
Analysis Population Description |
---|
Thirty (30) subjects received study products and were measured at the Baseline visit. Twenty-Nine (29) subjects completed the study thus, one subject dropped from the study prior to Day 60 and was not analyzed for the 60 day measure. |
Arm/Group Title | Oxalate Liquid & Gel Plus SnF2 Paste | Oxalate Liquid & Gel Plus NaF Paste |
---|---|---|
Arm/Group Description | Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Stannous fluoride paste, self applied Potassium oxalate: Professionally applied (liquid) and self applied (gel) Stannous fluoride paste: Toothpaste used by subject | Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Sodium fluoride paste, self applied Potassium oxalate: Professionally applied (liquid) and self applied (gel) Sodium fluoride paste: Toothpaste used by subject |
Measure Participants | 14 | 15 |
Mean (Standard Deviation) [Units on a scale] |
-1.643
(0.770)
|
-1.500
(0.906)
|
Title | Change From Baseline Visual Analog Scale |
---|---|
Description | Visual Analog Scale (VAS) - subjects are asked to look at a VAS and designate the level of hypersensitivity they experienced as a result of the thermal and water challenges using a continuum scale of 0 = No tooth pain up to 100 = Worst tooth pain ever experienced. |
Time Frame | 60 days |
Outcome Measure Data
Analysis Population Description |
---|
Thirty (30) subjects received study products. Twenty-Nine (29) subjects completed the study thus, one subject dropped from the study prior to Day 60 and was not analyzed for the 60 day measure. |
Arm/Group Title | Oxalate Liquid & Gel Plus SnF2 Paste | Oxalate Liquid & Gel Plus NaF Paste |
---|---|---|
Arm/Group Description | Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Stannous fluoride paste, self applied Potassium oxalate: Professionally applied (liquid) and self applied (gel) Stannous fluoride paste: Toothpaste used by subject | Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Sodium fluoride paste, self applied Potassium oxalate: Professionally applied (liquid) and self applied (gel) Sodium fluoride paste: Toothpaste used by subject |
Measure Participants | 14 | 15 |
Mean (Standard Deviation) [Units on a scale] |
-29.82
(18.65)
|
-24.67
(26.75)
|
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Oxalate Liquid & Gel Plus SnF2 Paste | Oxalate Liquid & Gel Plus NaF Paste | ||
Arm/Group Description | Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Stannous fluoride paste, self applied Potassium oxalate: Professionally applied (liquid) and self applied (gel) Stannous fluoride paste: Toothpaste used by subject | Potassium oxalate liquid, professionally applied Potassium oxalate gel, self applied Sodium fluoride paste, self applied Potassium oxalate: Professionally applied (liquid) and self applied (gel) Sodium fluoride paste: Toothpaste used by subject | ||
All Cause Mortality |
||||
Oxalate Liquid & Gel Plus SnF2 Paste | Oxalate Liquid & Gel Plus NaF Paste | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 1/14 (7.1%) | 0/15 (0%) | ||
Serious Adverse Events |
||||
Oxalate Liquid & Gel Plus SnF2 Paste | Oxalate Liquid & Gel Plus NaF Paste | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/14 (0%) | 0/15 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Oxalate Liquid & Gel Plus SnF2 Paste | Oxalate Liquid & Gel Plus NaF Paste | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 1/14 (7.1%) | 0/15 (0%) | ||
Gastrointestinal disorders | ||||
Hyperesthesia | 1/14 (7.1%) | 2 | 0/15 (0%) | 0 |
PAIN | 1/14 (7.1%) | 1 | 0/15 (0%) | 0 |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Clinical Trial Manager |
---|---|
Organization | The Procter & Gamble Company |
Phone | 513-622-2489 |
peters.j.2@pg.com |
- 2014069